Skip to main content
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.848
+0.042 (5.16%)
At close: Apr 28, 2026, 4:00 PM EDT
0.850
+0.003 (0.29%)
Pre-market: Apr 29, 2026, 4:38 AM EDT

Humacyte Revenue

In the year 2025, Humacyte had annual revenue of $2.04M. Humacyte had revenue of $467.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$2.04M
Revenue Growth
n/a
P/S Ratio
92.33
Revenue / Employee
$11,076
Employees
184
Market Cap
188.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.04M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20221.57M302.00K23.91%
Dec 31, 20211.26M-228.00K-15.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 149.50M
Precision BioSciences 34.26M
Tonix Pharmaceuticals Holding 13.11M
Korro Bio 6.39M
Cartesian Therapeutics 2.80M
Revenue Rankings

HUMA News

More News